[1]孙慧,李彩萍.雷公藤多苷联合二甲双胍治疗糖尿病肾病临床观察[J].西部中医药,2014,27(07):82-84.
　SUN Hui,LI Caiping.Clinical Observation on Tripterygium Glycosides and Metformin in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):82-84.
点击复制

雷公藤多苷联合二甲双胍治疗糖尿病肾病临床观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
27
期数:
2014年07期
页码:
82-84
栏目:
出版日期:
2014-07-15

文章信息/Info

Title:
Clinical Observation on Tripterygium Glycosides and Metformin in Treating Diabetic Nephropathy
文章编号:
004-6852(2014)07-0082-03
作者:
孙慧，李彩萍
内蒙古医科大学附属医院保健中心，内蒙古 呼和浩特 010050
Author(s):
SUN Hui, LI Caiping
Care Center of Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
关键词:
糖尿病肾病; 雷公藤多苷; 二甲双胍; 尿蛋白
Keywords:
diabetic nephropathy;  tripterygium glycosides;  metformin;  urine protein
分类号:
R259.871
摘要:
目的：探讨雷公藤多苷联合二甲双胍治疗糖尿病肾病(DN)的临床疗效。方法：将DN患者150例随机分为研究组(n=74)和对照组(n=76)，对照组予二甲双胍治疗，研究组予雷公藤多苷+二甲双胍治疗，疗程6个月。评价2组患者空腹血糖(FPG)、餐后2 h血糖(2 hPG)、收缩压(SBP)、舒张压(DBP)、24 h尿蛋白定量、尿白蛋白排泄率(UAE)、血肌酐(Ccr)和血尿素氮(BUN)改善情况。结果：上述各指标治疗后2组均明显下降，与治疗前比较差异具有统计学意义(P＜0.05)，治疗后2组FPG、2 hPG、SBP和DBP比较差异无统计学意义(P＞0.05)，但24小时尿蛋白定量、UAE、Ccr和BUN比较差异具有统计学意义(P＜0.05)。结论：雷公藤多苷联合二甲双胍治疗DN，能明显降低患者尿蛋白含量，改善肾功能，并能从根本上改善血压和血糖指标。
Abstract:
Objective: To explore therapeutic effects of tripterygium glycosides and metformin in treating diabetic nephropathy (DN). Methods: All 150 DN patients were randomly separated into the study group (n=74) and the control group (n=76). The control group took metformin, the study group tripterygium glycosides and metformin, all the patients were treated for six months. Fasting plasma glucose (FPG), 2 hour postprandial glucose (2hPG), systolic blood pressure (SBP), diastolic blood pressure (DBP), 24h urine protein, urinary albumin excretion (UAE), serum creatinine (Scr) and blood urea nitrogen (BUN) of the patients in both groups were assessed. Results: After treating, all the indexes of both groups were decreased remarkably, the difference presented statistical meaning compared with before treating (P＜0.05), after treating, the difference had no statistical meaning in the comparison of FPG, 2hPG, SBP and DBP between both groups (P＞0.05), but the difference demonstrated statistical meaning in 24h urine protein, UAE, Scr and BUN after treating between both group (P＜0.05). Conclusion: Tripterygium glycosides and metformin in treating DN could obviously decrease the contents of urine protein, improve renal function, blood pressure and the indexes of glucose completely.

相似文献/References:

[1]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
　LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68.
[2]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
　WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):62.
[3]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):77.
[4]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
　DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(07):96.
[5]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.
[6]刘涛.缬沙坦联合复方丹参滴丸对早期2型糖尿病肾病患者尿微量白蛋白的影响[J].西部中医药,2015,28(05):106.
[7]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
　LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68.
[8]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1.
[9]朱苗蕊,指导：金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
　ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):74.
[10]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
　MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):96.

备注/Memo

备注/Memo:
收稿日期：2013-08-25作者简介：孙慧(1972—)，女，硕士学位，副主任医师。研究方向：内分泌疾病的临床诊治。
更新日期/Last Update: 2014-07-15